INTERNATIONAL PATENT: EPIGENIC THERAPEUTICS, INC., 益杰立科（上海）生物科技有限公司 FILES APPLICATION FOR "ENGINEERED GENE TRANSCRIPTIONAL REPRESSION TOOL TARGETING HEPATITIS B VIRUS GENE AND USE THEREOF"

GENEVA, Jan. 11 -- EPIGENIC THERAPEUTICS, INC. (Floor 5&6, Unit 1, Building 4, No.160 Basheng RoadChina (Shanghai) Pilot Free Trade Zone, Pudong New AreaShanghai 200131), 益杰立科（上海）生物科技有限公司 (中国上海市浦东新区中国（上海）自由贸易试验区巴圣路160号4号楼1单元5层&6层) filed a patent application (PCT/CN2025/000022) for "ENGINEERED GENE TRANSCRIPTIONAL REPRESSION TOOL TARGETING HEPATITIS B VIRUS GENE AND USE THEREOF" on Jun 23, 2025. With publication...